v3.26.1
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
 3 Months Ended 12 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Dec. 31, 2025
Dec. 31, 2024
Cash Flows From Operating Activities:        
Net (loss) income $ (1,430,668) $ 9,194,630 $ (41,004,000) $ (32,417,033)
Adjustments to reconcile net loss to net cash used in operating activities:        
Depreciation and amortization 67,400 69,942 294,442 350,509
Stock based compensation 277,654 754,361 2,949,920 2,367,014
Equity compensation expense 671 3,821,122 1,976,000
Non-cash interest expense 90,450 303,061
Amortization of debt discount 30,110    
Non-cash gain related to adjustment of note payable balance     (257,512)
Change in fair value of derivative liabilities (561,350) (12,417,450) 28,250,727 (12,275,217)
Loss on issuance of common stock and warrants     31,033,622
Changes in operating assets and liabilities:        
Accounts receivable (10,514) (4,111) 1,165
Inventory     (1,700)
Prepaid expenses 103,439 (302,034) 36,527 3,515
Deferred offering costs (460,915)    
Other current assets (371,163) (607,376) (76,166)
Accounts payable and accrued expenses 2,043,286 867,249 1,404,126 1,344,669
Income taxes payable (6,369) (6,369) (82,898)
Excise taxes 95,858 13,648 54,592 19,486
Due to related party 75,000    
Net Cash Used In Operating Activities (141,863) (2,342,278) (4,536,702) (7,377,807)
Cash Flows From Investing Activities:        
Purchases of property and equipment     (117,812)
Capitalized patent costs (23,975) (40,156) (122,930) (246,074)
Net Cash Used In Investing Activities (23,975) (40,156) (240,742) (246,074)
Cash Flows From Financing Activities:        
Capital contributions from Global Graphene Group     487,273
Cash received from NUBI Trust     25,160,047
Discount payment related to Non Redemption Agreement     (13,937,997)
Reimbursement of consideration shares related to the Forward Purchase Agreement     (2,193,800)
Reimbursement of Recycled Shares related to Forward Purchase Agreement     (80,241)
Transaction expenses in connection with the Merger     (8,948,009)
Inflow from Merger     17,555
Proceeds from convertible notes     527,500
Proceeds from short-term notes     1,000,000 670,000
Repayment of short-term notes (42,671) (42,671) (1,389,146)
Proceeds from issuance of common stock and warrants in connection with Private Placement     7,850,000
Proceeds from issuance of common stock from exercise of warrants 241,546 671,568 4,259,241
Issuance costs in connection with Private Placement     (419,499)
Repayment of related party payable     (1,026,091)
Cash used to settle fractional shares     (460)
Net Cash Provided By Financing Activities 198,875 1,628,437 10,976,833
Net change in cash (165,838) (2,183,559) (3,149,007) 3,352,952
Cash at beginning of period 204,725 3,353,732 3,353,732 780
Cash at end of period 38,887 1,170,173 204,725 3,353,732
Supplemental disclosure        
Cash paid for interest expense 7,329 16,627 169,911
Cash paid for federal income taxes 6,369 6,369 89,959
Supplemental disclosure of non-cash financing activities:        
Issuance of Common Stock upon the closing of the Merger 414 4,993
Issuance of Common Stock for Forward Purchase Agreement     3,124,379
Issuance of Common Stock upon cashless exercise of warrants     11
Stock subscription receivable, net of discount     2,372,232
FPA discount accretion 78,247 295,841 93,113
Debt discount recognized on note payable 70,000    
Convertible notes converted to common shares 527,500 527,500
Reclassification of warrant derivative liability to additional paid-in capital upon exercise of Series A warrants     3,804,286
Conversion of Series C and Series D warrant derivative liabilities into common stock     43,030,502
Reverse stock split – reclassification from common stock to additional paid-in capital 13,311 13,311
Capitalized interest to principal balance of short-term note payable 90,450 29,777 24,061
Shares issued upon settlement of warrants $ 24 $ 1,915,988